NIB (ASX:NHF) and Medibank (ASX:MPL) Report Record-Low Premium Increases – Is It Time To Buy Sell?

NIB Holdings Limited (ASX:NHF) and Medibank Private Limited (ASX:MPL) have both reported their lowest premium increases in many years.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

NIB Holdings Limited (ASX: NHF) and Medibank Private Limited (ASX: MPL) have reported their lowest level of insurance premium increases in many years.

NIB Holdings and Medibank Private are two of Australia’s largest private health insurers. Medibank operates the low-cost ahm brand, whilst NIB operates the corporate health insurer GU Health Insurance.

Approved premium increases

The Federal Minister for Health has approved NIB to increase its insurance premiums by an average of 3.38% across all of its products. GU Health Insurance premiums will increase by an average of 1.8%.

The NIB increase is the lowest for 16 years. It also said it will implement reforms of including an introduction of discounts for members under the age of 30, classifying products into easy to understand tiers and offering the choice of a higher hospital excess for members.

NIB Managing Director Mark Fitzgibbon talked up his company’s efforts to make health insurance more affordable:

This is the fifth consecutive year we’ve been able to deliver an average premium change lower than the previous year reflecting our ongoing focus on cost containment and inflation.”

Meanwhile, Medibank said that Medibank and ahm premiums will increase by an average of 3.3%, which is the lowest increase in 18 years. Medibank also confirmed it is implementing the reforms.

To make up for the slow premium rises, Medibank is aiming to cut $60 million of costs to the end of FY20.

Is it Time to Buy Shares In Private Health Insurers?

In early trading today, the Medibank share price is up nearly 3% according to Google Finance, whilst NIB’s shares are up 0.6%.

I think Medibank’s CEO Craig Drummond may have said it best in the press release when he said: “The challenge remains, as to how we can continue to deliver quality healthcare in Australia, at an affordable price.”

Until the private health affordability issue is resolved it’s likely that policyholder growth will be low for Medibank and NIB, if not negative. For example, Australian wage growth is less than the premium rises each year, making it even harder for households to justify.

It could be a better move to pick healthcare shares that are creating growth regardless of the difficulty in private health affordability, such as the two growth shares outlined in the free

online pharmacy buy arimidex no prescription online pharmacy

report below.

[ls_content_block id=”14947″ para=”paragraphs”]

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.